Familial hypercholesterolemia class II low-density lipoprotein receptor response to statin treatment
Low-density lipoprotein (LDL) receptor (LDLR) mutations are the primary cause of familial hypercholesterolemia (FH). Class II LDLR mutations result in a misfolded LDLR retained in the endoplasmic reticulum (ER). We have developed a model of FH class II and CRISPR-corrected induced pluripotent stem c...
Saved in:
Main Authors: | Linda Omer (Author), Lubna Hindi (Author), Giuseppe Militello (Author), Katlin B. Stivers (Author), Kenneth C. Tien (Author), Nolan L. Boyd (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of sequence variations in low-density lipoprotein receptor gene among Malaysian patients with familial hypercholesterolemia
by: Yusof Zurkurnai, et al.
Published: (2011) -
Familial hypercholesterolemia in St.-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia
by: Konstantinov Vladimir O, et al.
Published: (2005) -
Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
by: Akl C. Fahed, et al.
Published: (2012) -
Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statins
by: Harold E. Bays, et al.
Published: (2021) -
Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency
by: Chinwong D, et al.
Published: (2015)